SALVAGNI, SANDRO
SALVAGNI, SANDRO
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.009 secondi).
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins
2018 Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A
Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature
2021 Lo Preiato V.; Salvagni S.; Ricci C.; Ardizzoni A.; Pagotto U.; Pelusi C.
Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
2020 Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A.
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
2020 Gatti M.; Raschi E.; Poluzzi E.; Martignani C.; Salvagni S.; Ardizzoni A.; Diemberger I.